论文部分内容阅读
目的:探讨艾愈胶囊辅助化疗治疗胃癌的临床疗效及其安全性。方法:选取湖南省肿瘤医院在2013年4月至2014年5月收治的胃癌患者84例为研究对象,随机分为观察组与对照组。对照组给予单纯化疗治疗,观察组在对照组的基础上给予艾愈胶囊治疗。对两组近期疗效及发生毒副反应情况进行对比。结果:观察组的疾病控制率与总有效率分别是90.48%、45.24%,对照组疾病控制率与总有效率分别为61.90%、27.50%,观察组显著升高,差异有统计学意义(P<0.05);与对照组相比,观察组患者血红蛋白减少、恶心呕吐的发生率显著降低,差异有统计学意义(P<0.05)。结论:艾愈胶囊辅助化疗治疗胃癌能够显著提高疗效,减轻白细胞减少症。
Objective: To investigate the clinical efficacy and safety of Aiyu capsule adjuvant chemotherapy in the treatment of gastric cancer. Methods: Totally 84 patients with gastric cancer who were treated in Hunan Cancer Hospital from April 2013 to May 2014 were selected as study subjects and randomly divided into observation group and control group. The control group was treated with chemotherapy alone, and the observation group was treated with Aiyu capsule on the basis of the control group. The two groups of recent curative effect and the occurrence of side effects were compared. Results: The disease control rate and total effective rate in the observation group were 90.48% and 45.24% respectively. The control rate and total effective rate in the control group were 61.90% and 27.50% respectively. The observation group was significantly increased (P <0.05). Compared with the control group, the incidence of hemoglobin decrease and nausea and vomit in observation group decreased significantly (P <0.05). Conclusion: Aiyu Capsule adjuvant chemotherapy for gastric cancer can significantly improve the efficacy and reduce leukopenia.